---
category: news
title: "Focus On - Deals, Digital Pharma"
excerpt: "London-listed Poolbeg Pharma has signed an agreement with OneThree Biotech to identify new drug targets and treatments for respiratory syncytial virus (RSV). Licensing deals featured prominently in last weekâ€™s news,"
publishedDateTime: 2022-04-07T23:03:00Z
originalUrl: "https://www.thepharmaletter.com/listing/focus-on/deals-digital-pharma?tagid[]=18442&tagid[]=62610"
webUrl: "https://www.thepharmaletter.com/listing/focus-on/deals-digital-pharma?tagid[]=18442&tagid[]=62610"
type: article
quality: 4
heat: 4
published: false

provider:
  name: The Pharma Letter
  domain: thepharmaletter.com

topics:
  - AI in Healthcare
  - AI

secured: "qdfNTU83jKfdUYY9v1UoJ5sgXdO3bYua68vpGyqPMOXgO5GWL+NAr237f9DGmt9WU5J8RaLCwArY4mZgmoVodqWChlBQMIBXPFalG+uPW2qrpC56jsO//mZ/mYqwhlpMjAkA/Oj4YsM10vQlvGa7yvjWusKEt7rynqXlAdgrVm6y1BSUPEPZmUjh5JDOrKN+2igKC5FNUuaGeDuM9sfS2BsBkl6Lq4nIVbU9FgZd0CSihNLSw+Tjz75eqUP1B7zu37WUAIitQg7TUlvypMMGIzouN9b4qFdr2HOcBtDid+zFSRWptMEUoB0DrEAHsOOaGRsOPvle7yRXBtTshdGxNe6zlt+bJJj4ROAY0y/bt1E=;9kTjcaBGZo22sQHYGPsUTQ=="
---

